Power Law company profile

BeOne Medicines

Biotech & Life Sciences · Dongcheng District, China · Founded 2010 · IPO 2016 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$29B

Market cap · 2026

Revenue

$5.34B

Latest reported FY

Investors

3 investors on BeOne Medicines's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

CITIC Capital

Hillhouse Capital

Series B+ 1 investor entered at this stage

Rock Springs Capital

Global footprint

Where BeOne Medicines has talent and traffic

AI talent share

0.5% of workforce is AI talent
(11 of 2,163 staff)

Core AI20.09%

Other AI90.42%

Non-AI workforce2,15299.49%

Web traffic by country

56K monthly visits
across markets

🇺🇸 United States42.1%

🇨🇭 Switzerland15.4%

🇬🇧 United Kingdom12.1%

🇮🇳 India4.1%

🇸🇬 Singapore2.7%

Top 5 markets shown

Patent intelligence

$250M patent portfolio · 425 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$250M

0.87% of market cap · 3.1× smaller than top peer BioNTech ($780M)

425 active patent families

Where BeOne Medicines innovates Molecular biologyDiseaseCarcinosisAntiendomysial antibodiesAntigen Binding Fragment

Above peer median on Strategic · Below peer median on Market

Quality vs same-sector peers

BeOne Medicines on the five Patsnap quality dimensions

BeOne Medicines in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where BeOne Medicines concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across BeOne Medicines and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See BeOne Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo